HPGC Renmintongtai Pharmaceutical Corporation announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was CNY 6,177.849 million compared to CNY 5,346.024 million a year ago. Operating income was CNY 280.314 million compared to CNY 272.229 million a year ago. Net income was CNY 209.399 million compared to CNY 202.048 million a year ago. Basic earnings per share from continuing operations was CNY 0.3611 compared to CNY 0.3484 a year ago.